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Previews“Sweet Talk”: Closing in
on C Type Lectin Signaling
C type lectins recognize pathogens by binding to
pathogen-specific carbohydrate residues. The finding
reported by Rogers et al. (2005) in this issue of Immu-
nity, that ligand binding by the C type lectin Dectin-1
leads to recruitment of the tyrosine kinase Syk and is
critical to subsequent cytokine production by the cell,
will surely inspire further research on the mecha-
nisms of carbohydrate receptor signaling.
The role of carbohydrate-mediated interactions in pro-
cesses as diverse as tissue homing, enzyme trafficking,
and immune responses has received increasing atten-
tion during the past few years, with carbohydrate re-
ceptors such as the C type lectins becoming a major
research focus in immunology and microbiology. Many
C type lectins belong to the larger family of pattern re-
cognition receptors (PRRs) that detect conserved path-
ogen-associated molecular patterns (PAMPs), helping
to distinguish self from nonself and modulating immune
responses against pathogens. C type lectins are ex-
pressed by a broad spectrum of cells, including den-
dritic cells (DCs) and other antigen-presenting cells.
Characteristically, C type lectins contain one or multiple
carbohydrate recognition domains. By binding to car-
bohydrates in a calcium-dependent manner, they re-
cognize subtle structural differences in carbohydrate
residue arrangement or branching (Drickamer, 1999). In
antigen-presenting cells, they are mainly involved in an-
tigen uptake and degradation to enhance antigen pro-
cessing and presentation (Figdor et al., 2002). Several
C type lectin receptors contain signaling motifs such
as the immunoreceptor tyrosine-based activation motif
(ITAM) or the immunoreceptor tyrosine-based inhibition
motif (ITIM) in their cytoplasmic domains (Billadeau and
Leibson, 2002), and this has led to speculation about
the signaling capacity of this family of molecules. In-
deed, Dectin-1, the major β-glucan receptor of mac-
rophages, contains a cytoplasmic ITAM motif, and
Gantner et al. have demonstrated cooperative func-
tional signaling involving Dectin-1 and the Toll-like re-
ceptor TLR2 (Brown et al., 2003; Gantner et al., 2003).
Nevertheless, this study did not determine the specific
mechanism by which this pair of receptors activated
the macrophage.
Rogers et al. (2005) now show that binding of a li-
gand, the yeast cell wall (zymosan), to the C type lectin
receptor Dectin-1 leads to recruitment of the protein
tyrosine kinase Syk, which in turn induces cytokine
production. The authors have performed gain-of-func-
tion experiments with a Dectin-1-transfected murine B
cell hybridoma cell line. They demonstrate convincingly
that Dectin-1 triggering by zymosan induces IL-10 and
IL-2 production that is completely inhibitable by theDectin-1 antagonist glucan phosphate. Cells express-
ing a truncated version of Dectin-1 lacking the cyto-
plasmic domain were able to bind zymosan, but did not
produce IL-10 or IL-2 in response to the stimulus.
These findings prompted the authors to take a closer
look at the cytoplasmic Dectin-1 domain with regard
to signaling function. In subsequent experiments, the
authors could coprecipitate recombinant and endoge-
nous Syk with peptides corresponding to the phos-
phorylated cytoplasmic tail of Dectin-1. Interestingly,
only phosphorylation of the membrane proximal tyro-
sine residue within the ITAM-like sequence of Dectin-1
was required for Syk recruitment and induction of IL-2
and IL-10 production in transfected cells. This is in con-
trast to the binding characteristics of Syk, which nor-
mally require an ITAM with two phosphorylated tyrosine
residues for binding and kinase activation. Finally, the
authors examined the function of Syk−/− bone marrow-
derived dendritic cells. They demonstrate that Syk-defi-
cient DCs bind to zymosan and produce normal levels
of IL-12 but that they cannot produce IL-2 and IL-10 in
response to zymosan. Interestingly, in contrast to prior
findings in macrophages (Herre et al., 2004), Syk-defi-
cient DCs also show deficient zymosan phagocytosis.
Several open questions remain. First of all, what is
the physiological relevance of the in vitro finding that
phosphorylation of just the membrane proximal tyro-
sine residue in the Dectin-1 cytoplasmic tail is neces-
sary and sufficient for zymosan induction of cytokine
production requires further examination. It will be inter-
esting to determine whether Dectin-1 becomes phos-
phorylated at only that membrane proximal tyrosine
residue after ligand binding in vivo or if both tyrosines
are modified, and if so, whether both sites play a role
in situ that was not discernible in culture. The authors
use zymosan as a substitute for pathogens such as
Candida albicans. Zymosan contains a very high con-
centration of β-glucans. Results obtained by zymosan
triggering may therefore not accurately reflect the re-
sults of triggering with a natural ligand. Recently,
Gantner et al. showed that in Candida albicans β-glu-
can is shielded from Dectin-1 by outer cell wall compo-
nents and that yeast budding and cell separation create
scars that expose sufficient amounts of β-glucan for
Dectin-1 triggering on macrophages. During filamen-
tous growth of Candida albicans, β-glucan is not ex-
posed. Dectin-1 is therefore not triggered, possibly al-
lowing the pathogen to evade an immune response
(Gantner et al., 2005). To further understand the mecha-
nisms of zymosan-mediated Dectin-1 triggering, it
would be interesting to know if the effects of zymosan
can be mimicked by natural ligands or perhaps by sim-
ply crosslinking with Dectin-1 antibodies.
The authors could not coimmunoprecipitate Syk with
Dectin-1 from zymosan-stimulated cells. The present
data thus do not rule out an indirect interaction be-
tween Dectin-1 and Syk, although they strongly sug-
gest a direct interaction despite this lack of coprecipita-
tion. Considering the complexity of the PAMPs
expressed by Candida albicans, it is possible that other,
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400yet-unknown receptors play a cooperative role in zymo- n
rsan-mediated Syk recruitment to Dectin-1. The docu-
mented cooperative signaling by Dectin-1 and TLR2 is f
tperhaps relevant in this regard. The interaction of zy-
mosan with a DC can have diverse effects (Figure 1).
Binding to TLR2 can trigger TNF-α and IL-12 pro- F
Gduction that is augmented by cooperative signaling
with Dectin-1. Triggering of Dectin-1 alone leads to IL- D
N10 and IL-2 secretion as described in the present study
of Rogers et al. (2005). To fully understand these ef- R
Pfects, it will be pivotal to determine the underlying
mechanisms regulating which receptors interact with a 6
Tpathogen at given time point. The host-pathogen in-
terplay is most likely a highly dynamic process. A path-
ogen will display multiple PAMPs that interact with vari-
Sous PRRs on the same antigen-presenting cell. The
arrangement of receptors in microdomains on the cell
B
membrane of DC and macrophages may directly influ- 1
ence the response. We have shown that a significant B
portion of the C type lectin DC-SIGN resides in the de- a
tergent-resistant membrane fraction, where lipid rafts C
can also be found (Cambi et al., 2004). Another exam- t
Pple of a C type lectin colocalizing with lipid rafts is
E-selectin. Intriguingly, the presence of E-selectin in D
lipid rafts proved to be mandatory for its association F
mwith, and activation of, PLCγ, suggesting that this sub-
Gcellular localization of E-selectin is important for its sig-
dnaling function(s) during leukocyte-endothelial interac-
Gtions (Kiely et al., 2003).
2The present paper of Rogers et al. (2005) emphasizes
Hthe concept that through their detection of pathogen-
Sderived carbohydrate patterns, C type lectin receptors
B
play a prominent role in shaping the adaptive immune
K
response to pathogens. C type ligand binding not only J
leads to improved internalization and presentation of
R
antigens, but it also induces direct cellular signaling S
events, resulting in cytokine production and skewing B
5of the immune response. Understanding the complexFigure 1. The Yeast Cell Wall (Zymosan) Can
Interact with the PRRs Dectin-1 and TLR2
Receptor triggering has diverse effects,
ranging from IL-2 and IL-10 production in the
case of Dectin-1 triggering alone to IL-12
and TNF-α production in the case of TLR2
activation. The latter is augmented by coop-
erative signaling of Dectin-1 with TLR2. One
of the future challenges is to determine the
mechanisms regulating the interplay between
different receptors after pathogen binding.etwork of PRRs and their effect on the host immune
esponse is the present challenge. The objective for the
uture is to translate this knowledge into diagnostic and
herapeutic tools for immune-mediated diseases.
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